Literature DB >> 22243961

Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles.

Yong-Kang Zhang1, Jacob J Plattner, Yvonne R Freund, Eric E Easom, Yasheen Zhou, Long Ye, Huchen Zhou, David Waterson, Francisco-Javier Gamo, Laura M Sanz, Min Ge, Zhiya Li, Lingchao Li, Hailong Wang, Han Cui.   

Abstract

A series of new boron-containing benzoxaborole compounds was designed and synthesized for a continuing structure-activity relationship (SAR) investigation to assess the antimalarial activity changes derived from side-chain structural variation, substituent modification on the benzene ring and removal of boron from five-membered oxaborole ring. This SAR study demonstrated that boron is required for the antimalarial activity, and discovered that three fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles (9, 14 and 20) have excellent potencies (IC(50) 0.026-0.209 μM) against Plasmodium falciparum.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22243961     DOI: 10.1016/j.bmcl.2011.12.096

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

1.  The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.

Authors:  Jonathan D Herman; Lauren R Pepper; Joseph F Cortese; Guillermina Estiu; Kevin Galinsky; Vanessa Zuzarte-Luis; Emily R Derbyshire; Ulf Ribacke; Amanda K Lukens; Sofia A Santos; Vishal Patel; Clary B Clish; William J Sullivan; Huihao Zhou; Selina E Bopp; Paul Schimmel; Susan Lindquist; Jon Clardy; Maria M Mota; Tracy L Keller; Malcolm Whitman; Olaf Wiest; Dyann F Wirth; Ralph Mazitschek
Journal:  Sci Transl Med       Date:  2015-05-20       Impact factor: 17.956

2.  Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles.

Authors:  Katrien Van Bocxlaer; Eric Gaukel; Deirdre Hauser; Seong Hee Park; Sara Schock; Vanessa Yardley; Ryan Randolph; Jacob J Plattner; Tejal Merchant; Simon L Croft; Robert T Jacobs; Stephen A Wring
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

Review 3.  Recent advances in malaria drug discovery.

Authors:  Marco A Biamonte; Jutta Wanner; Karine G Le Roch
Journal:  Bioorg Med Chem Lett       Date:  2013-03-27       Impact factor: 2.823

Review 4.  Synthesis of biologically active boron-containing compounds.

Authors:  Fei Yang; Mingyan Zhu; Jinyi Zhang; Huchen Zhou
Journal:  Medchemcomm       Date:  2017-11-28       Impact factor: 3.597

5.  Expanding Benzoxazole-Based Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Inhibitor Structure-Activity As Potential Antituberculosis Agents.

Authors:  Shibin Chacko; Helena I M Boshoff; Vinayak Singh; Davide M Ferraris; Deviprasad R Gollapalli; Minjia Zhang; Ann P Lawson; Michael J Pepi; Andrzej Joachimiak; Menico Rizzi; Valerie Mizrahi; Gregory D Cuny; Lizbeth Hedstrom
Journal:  J Med Chem       Date:  2018-05-30       Impact factor: 7.446

6.  Benzoxaborole antimalarial agents. Part 4. Discovery of potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles.

Authors:  Yong-Kang Zhang; Jacob J Plattner; Eric E Easom; Robert T Jacobs; Denghui Guo; Virginia Sanders; Yvonne R Freund; Brice Campo; Philip J Rosenthal; Wei Bu; Francisco-Javier Gamo; Laura M Sanz; Min Ge; Liang Li; Jie Ding; Yin Yang
Journal:  J Med Chem       Date:  2015-06-23       Impact factor: 7.446

Review 7.  tRNAs as antibiotic targets.

Authors:  Shaileja Chopra; John Reader
Journal:  Int J Mol Sci       Date:  2014-12-25       Impact factor: 5.923

8.  A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue.

Authors:  Ebere Sonoiki; Caroline L Ng; Marcus C S Lee; Denghui Guo; Yong-Kang Zhang; Yasheen Zhou; M R K Alley; Vida Ahyong; Laura M Sanz; Maria Jose Lafuente-Monasterio; Chen Dong; Patrick G Schupp; Jiri Gut; Jenny Legac; Roland A Cooper; Francisco-Javier Gamo; Joseph DeRisi; Yvonne R Freund; David A Fidock; Philip J Rosenthal
Journal:  Nat Commun       Date:  2017-03-06       Impact factor: 14.919

Review 9.  Organoboron Compounds: Effective Antibacterial and Antiparasitic Agents.

Authors:  Paolo Saul Coghi; Yinghuai Zhu; Hongming Xie; Narayan S Hosmane; Yingjun Zhang
Journal:  Molecules       Date:  2021-05-31       Impact factor: 4.411

10.  The trypanocidal benzoxaborole AN7973 inhibits trypanosome mRNA processing.

Authors:  Daniela Begolo; Isabel M Vincent; Federica Giordani; Ina Pöhner; Michael J Witty; Timothy G Rowan; Zakaria Bengaly; Kirsten Gillingwater; Yvonne Freund; Rebecca C Wade; Michael P Barrett; Christine Clayton
Journal:  PLoS Pathog       Date:  2018-09-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.